World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 25 May 2015
Main ID:  NCT02436746
Date of registration: 29/04/2015
Prospective Registration: No
Primary sponsor: Erasmus Medical Center
Public title: The Cognitive Variability in NF1 and TSC Monozygotic Twins COVANTT
Scientific title: The Cognitive Variability in Neurofibromatosis Type I and Tuberous Sclerosis Complex Monozygotic Twins
Date of first enrolment: April 2015
Target sample size: 116
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT02436746
Study type:  Observational
Study design:  Observational Model: Cohort, Time Perspective: Cross-Sectional  
Phase:  N/A
Countries of recruitment
Netherlands
Contacts
Name:     Ype Elgersma, Prof.
Address: 
Telephone: +31 10 7037739
Email: y.elgersma@erasmusmc.nl
Affiliation: 
Name:     Ype Elgersma, Prof.
Address: 
Telephone: +31 10 7037739
Email: y.elgersma@erasmusmc.nl
Affiliation: 
Name:     Ype Elgersma, Prof.
Address: 
Telephone:
Email:
Affiliation:  Erasmus MC
Key inclusion & exclusion criteria

Inclusion Criteria:

- The participant is part of a monozygotic twin pair (which is genetically confirmed);

- NF1 or TSC patients with a genetically confirmed diagnosis;

- Oral and written informed consent by participant in case = 18 years of age.

- Oral and written informed consent by both caregivers and assent by participant in
case of minor participants.

Exclusion Criteria:

- A potential subject of whom the twin sibling is not willing or able to participate in
this study, will be excluded from participation in this study.

- Symptomatic brain pathology.



Age minimum: N/A
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Tuberous Sclerosis Complex
Neurofibromatosis Type I
Intervention(s)
Primary Outcome(s)
Correlation of full intelligence quotient [Time Frame: 1 day]
Secondary Outcome(s)
Correlation of attention problems [Time Frame: 1 day]
Correlation of behavioural problems [Time Frame: 1 day]
Correlation of autistic features [Time Frame: 1 day]
Correlation of word reading ability [Time Frame: 1 day]
Correlation of executive control (TSC twins only) [Time Frame: 1 day]
Correlation of visuospatial judgement (NF1 twins only) [Time Frame: 1 day]
Secondary ID(s)
MEC-2014-483
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history